XML 51 R37.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Stock-Based Compensation (Tables) | 3 Months Ended
--- | ---
Jun. 30, 2024
Equity [Abstract] |
Schedule Of Share-Based Payment Award, Restricted Stock Purchase Plan, Valuation Assumptions | The assumptions used in the Monte-Carlo simulation model to value our market-based restricted stock units were as follows:
| Three Months Ended June 30,
| 2024 |  | 2023 |  |
Risk-free interest rate | 4.5 | % |  | 4.4 | % |  |
Expected volatility | 23 - 43% |  | 25 - 59% |  |
Weighted-average volatility | 31 | % |  | 39 | % |  |
Expected dividends | None |  | None |  |
Schedule of Repurchase Agreements | The following table summarizes total shares repurchased during the three months ended June 30, 2024 and 2023:
| August 2022 Program |  | May 2024 Program |  | Total |  |  |  |
(In millions) | Shares |  | Amount(a) |  | Shares |  | Amount(a) |  | Shares |  | Amount |  |  |  |  |  |  |  |
Three months ended June 30, 2024 | 1.2 |  |  | $ | 152 |  |  | 1.6 |  |  | $ | 223 |  |  | 2.8 |  |  | $ | 375 |  |  |  |  |  |  |  |  |
Three months ended June 30, 2023 | 2.6 |  |  | $ | 325 |  |  | — |  |  | $ | — |  |  | 2.6 |  |  | $ | 325 |  |  |  |  |  |  |  |  |
(a)Amount excludes excise taxes. Accrued excise taxes are included in accrued and other current liabilities and additional paid-in capital on the Condensed Consolidated Balance Sheets.
Disclosure Of Stock-Based Compensation Arrangements By Stock-Based Payment Award | The following table summarizes our stock option activity for the three months ended June 30, 2024:
|  | Options (in thousands) |  | Weighted- Average Exercise Prices |  | Weighted- Average Remaining Contractual Term (in years) |  | Aggregate Intrinsic Value (in millions)
Outstanding as of March 31, 2024 |  | 12 |  |  | $ | 64.00 |  |  |  |  |
Granted |  | 1 |  |  | 128.18 |  |  |  |  |
Exercised |  | (2) |  |  | 86.43 |  |  |  |  |
Forfeited, cancelled or expired |  | (1) |  |  | 58.76 |  |  |  |  |
Outstanding as of June 30, 2024 |  | 10 |  |  | $ | 63.91 |  |  | 3.80 |  | $ | 1 |
Vested and expected to vest |  | 10 |  |  | $ | 63.91 |  |  | 3.80 |  | $ | 1 |
Exercisable as of June 30, 2024 |  | 10 |  |  | $ | 63.91 |  |  | 3.80 |  | $ | 1 |
The following table summarizes our restricted stock units activity for the three months ended June 30, 2024:
| Restricted Stock Units (in thousands) |  | Weighted- Average Grant Date Fair Values
Outstanding as of March 31, 2024 | 7,480 |  |  | $ | 128.31 |
Granted | 3,856 |  |  | 137.01 |
Vested | (2,204) |  |  | 130.65 |
Forfeited or cancelled | (135) |  |  | 129.29 |
Outstanding as of June 30, 2024 | 8,997 |  |  | $ | 131.45 |
The following table summarizes our performance-based restricted stock unit activity, presented with the maximum number of shares that could potentially vest, for the three months ended June 30, 2024:
| Performance- Based Restricted Stock Units (in thousands) |  | Weighted- Average Grant Date Fair Value
Outstanding as of March 31, 2024 | 836 |  |  | $ | 129.60 |
Granted | 763 |  |  | 137.53 |
Vested | (277) |  |  | 133.67 |
Forfeited or cancelled | (318) |  |  | 129.29 |
Outstanding as of June 30, 2024 | 1,004 |  |  | $ | 134.60 |
The following table summarizes our market-based restricted stock unit activity, presented with the maximum number of shares that could potentially vest, for the three months ended June 30, 2024:
| Market-Based Restricted Stock Units (in thousands) |  | Weighted- Average Grant Date Fair Value
Outstanding as of March 31, 2024 | 354 |  |  | $ | 168.53 |
Granted | 381 |  |  | 80.91 |
Vested | (25) |  |  | 173.25 |
Forfeited or cancelled | (73) |  |  | 173.25 |
Outstanding as of June 30, 2024 | 637 |  |  | $ | 115.43 |
The following table summarizes stock-based compensation expense resulting from stock options, restricted stock units, market-based restricted stock units, performance-based restricted stock units, and the ESPP purchase rights included in our Condensed Consolidated Statements of Operations (in millions):
| Three Months Ended June 30, |  |
| 2024 |  | 2023 |  |  |  |
Cost of revenue | $ | 4 |  |  | $ | 2 |  |  |  |  |
Research and development | 101 |  |  | 93 |  |  |  |  |
Marketing and sales | 12 |  |  | 11 |  |  |  |  |
General and administrative | 26 |  |  | 24 |  |  |  |  |
Stock-based compensation expense | $ | 143 |  |  | $ | 130 |  |  |  |  |

X
- Definition Schedule Of Share-Based Payment Award, Restricted Stock Purchase Plan, Valuation Assumptions + References No definition available. + Details
Name: | ea_ScheduleOfShareBasedPaymentAwardRestrictedStockPurchasePlanValuationAssumptionsTableTextBlock
Namespace Prefix: | ea_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for repurchase agreements. + References No definition available. + Details
Name: | us-gaap_ScheduleOfRepurchaseAgreements
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration